Results 111 to 120 of about 6,904 (161)

Reporting profile of adverse events following DTaP-IPV/Hib pentavalent vaccine: A 13-year real-world surveillance data analysis. [PDF]

Hum Vaccin Immunother
Zhang C, Liu X, Han L, Shen J.
europepmc   +1 more source

Optimizing preparedness and response for circulating vaccine derived poliovirus (cVDPV) outbreaks in the Eastern Mediterranean Region with a particular focus on cVDPV2. [PDF]

Front Public Health
Haddad N, Jarour N, Shukla H, Tsega A, Akbar I, Mahmoud Qasim Shahrour G, Sekhar Kar S, Al Nsour M, Gunaid M, Khader Y.   +9 more
europepmc   +1 more source

Changed Trends in Utilization and Substitution Pattern of Non-National Immunization Program Vaccines in Central China, 2011-2024. [PDF]

Vaccines (Basel)
Wang L, Li H, Zhang L, Li D.
europepmc   +1 more source

Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.

Releve epidemiologique hebdomadaire, 2006
openaire   +1 more source

Mono-WNV and combined WNV/TBEV inactivated vaccine efficacy against a wide range of WNV and TBEV strains. [PDF]

Front Immunol
Tuchynskaya K, Vorovitch M, Kruglov Y, Mostipanova G, Kholodilov I, Ivanova A, Kuchina V, Rogova A, Karganova G.   +8 more
europepmc   +1 more source

Tracking poliovirus through wastewater: environmental surveillance insights from Haïti (2020-2023). [PDF]

Appl Environ Microbiol
Belgasmi-Allen H, Hill J, Jeffries Miles S, Sayyad L, Elahi H, Patterson NE, Deas A, Heberlienne A, Wilkinson A, Vega E, Burns CC, Gerloff N.   +11 more
europepmc   +1 more source

Recent emergence of vaccine-derived poliovirus type 2 in Senegal and virus spread to neighboring countries.

Int J Infect Dis
Ndiaye N, Diop B, Kébé O, NGom SFM, Boussiengui LG, Dosseh A, Sam A, Dia M, Sy B, Diallo A, Gueye TN, Diaw PC, Ba IO, Chia JE, Diallo JP, Diallo B, Sall Y, Sall AA, Faye O, Dia N, Diop OM, Sow A, Anfumbom K, Faye M.   +23 more
europepmc   +1 more source

Replication not required: mRNA vaccines take on non-enveloped viruses. [PDF]

Mol Ther Nucleic Acids
Erasmus JH.
europepmc   +1 more source

Invasive meningococcal disease in adolescents in Europe and select geographies: Disease burden, unmet medical need, and optimizing prevention. [PDF]

Hum Vaccin Immunother
Andani A, Abbing-Karahagopian V, Kavaliauskaite J, Schaffner TO, Sohn WY, Graña MG, Marshall H, Martinon-Torres F, Bonanni P, Rappuoli R, Taha MK.   +10 more
europepmc   +1 more source